Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
4.300
+0.260 (6.44%)
Jul 27, 2026, 12:23 PM EDT - Market open
Outset Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -74.85 | -81.65 | -127.98 | -172.8 | -162.96 | -131.94 |
Depreciation & Amortization | 3.84 | 4.34 | 5.73 | 5.81 | 5.17 | 5.16 |
Stock-Based Compensation | 16.09 | 15.62 | 29.36 | 38.63 | 27.2 | 17.45 |
Other Adjustments | 5.11 | 13.17 | 2.28 | -2.25 | 6 | 4.67 |
Change in Receivables | 8.65 | 3.78 | -5.01 | -5.09 | -2.51 | -19.14 |
Changes in Inventories | 5.86 | 11.79 | -10.86 | 1.65 | -14.73 | -22.04 |
Changes in Accounts Payable | 0.34 | -3.29 | -1.95 | 5.31 | -1.28 | -3.07 |
Changes in Accrued Expenses | 3.99 | -5.13 | -8.83 | -5.05 | -1.7 | 14.78 |
Changes in Unearned Revenue | -0.99 | 0.6 | 1.77 | 3.02 | 2.16 | 2.88 |
Changes in Other Operating Activities | -1.56 | -5.55 | -0.81 | -0.61 | -3.09 | 0.98 |
Operating Cash Flow | -33.51 | -46.33 | -116.3 | -131.37 | -145.73 | -130.26 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.74 | -0.8 | -0.91 | -3.44 | -8.33 | -3.11 |
Purchases of Investments | -148.53 | -221.97 | -156.58 | -172.28 | -261.15 | -178.43 |
Proceeds from Sale of Investments | 137.57 | 125.08 | 261.43 | 258.75 | 203.18 | 39.03 |
Investing Cash Flow | -11.71 | -97.68 | 103.94 | 83.03 | -66.3 | -142.51 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 98.27 | 66.52 | 33.23 | 96.06 | - |
Long-Term Debt Repaid | - | -204.95 | - | - | -31.2 | - |
Net Long-Term Debt Issued (Repaid) | - | -106.68 | 66.52 | 33.23 | 64.86 | - |
Issuance of Common Stock | 0.74 | 0.64 | 2.28 | 10.43 | 8.04 | 160.15 |
Net Common Stock Issued (Repurchased) | 0.74 | 0.64 | 2.28 | 10.43 | 8.04 | 160.15 |
Issuance of Preferred Stock | -0.38 | 161.55 | - | - | - | - |
Net Preferred Stock Issued (Repurchased) | -0.38 | 161.55 | - | - | - | - |
Other Financing Activities | -0.01 | - | -0.94 | - | - | - |
Financing Cash Flow | 0.35 | 55.5 | 67.87 | 43.65 | 72.9 | 160.15 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -44.87 | -88.51 | 55.51 | -4.7 | -139.13 | -112.62 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -34.25 | -47.13 | -117.22 | -134.81 | -154.05 | -133.37 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -29.13% | -39.44% | -103.10% | -103.40% | -133.53% | -129.99% |
Free Cash Flow Per Share | -1.91 | -3.10 | -33.85 | -40.79 | -47.98 | -43.88 |
Levered Free Cash Flow | -64.1 | -186.37 | -77.31 | -132.88 | -119.89 | -136.35 |
Unlevered Free Cash Flow | -55.74 | -64.15 | -128.8 | -162.56 | -182.52 | -134.73 |